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Mutation of the Angelman Ubiquitin Ligase in Mice
Causes Increased Cytoplasmic p53 and Deficits
of Contextual Learning and Long-Term Potentiation
p53 in the absence of E6 (Beer-Romero et al., 1997;
Daniels et al., 1998; Talis et al., 1998), and the physiologi-
cal significance of any interaction between E6-AP and
p53 in the absence of viral proteins is unknown. Ubiquiti-
nation is critical for proteasomal degradation of proteins
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and plays a role in numerous cellular processes includ-2 Department of Pathology
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gen processing, synaptic plasticity, and transcription4 Division of Neuroscience
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AS is characterized by severe cognitive impairment,6 and Howard Hughes Medical Institute
absent speech, tremor, ataxia, seizures, dysmorphic fa-Houston, Texas 77030
cial features, inappropriate laughter, and sleep distur-
bance (Robb et al., 1989; Williams et al., 1995). About
70% of patients with AS have de novo deletions of z4Summary
Mb on the maternal homolog of human chromosome
15q11-q13. This chromosomal region is homologous toThe E6-AP ubiquitin ligase (human/mouse gene UBE3A/
a segment of mouse chromosome 7, and many genesUbe3a) promotes the degradation of p53 in association
in the region are subject to genomic imprinting (Lalande,with papilloma E6 protein, and maternal deficiency
1996; Bartolomei and Tilghman, 1997; Glenn et al., 1997).causes human Angelman syndrome (AS). Ube3a is im-
A small fraction of patients with AS have paternal unipa-printed with silencing of the paternal allele in hippo-
rental disomy (UPD), resulting in maternal deficiency,campus and cerebellum in mice. We found that the
with two paternal copies of the region and no maternalphenotype of mice with maternal deficiency (m2/p1)
copy. Another small group of AS patients have biparen-for Ube3a resembles human AS with motor dysfunc-
tal inheritance of chromosome 15q11-q13, but bothtion, inducible seizures, and a context-dependent
chromosomes have the paternal methylation and ex-learning deficit. Long-term potentiation (LTP) was se-
pression pattern (epigenotype); these ªimprinting muta-verely impaired in m2/p1 mice despite normal base-
tionsº are often associated with small deletions at aline synaptic transmission and neuroanatomy, indicat-
putative imprinting center (Sutcliffe et al., 1994; Buitinging that ubiquitination may play a role in mammalian
et al., 1995; Horsthemke et al., 1997). The identificationLTP and that LTP may be abnormal in AS. The cyto-
of loss of function mutations in the human UBE3A locusplasmic abundance of p53 was increased in postmi-
encoding E6-AP in a subset of patients with the typicaltotic neurons in m2/p1 mice and in AS, providing a
AS phenotype (Kishino et al., 1997; Matsuura et al., 1997)potential biochemical basis for the phenotype through
provides strong evidence that AS is caused primarily byfailure to ubiquitinate and degrade various effectors.
maternal deficiency of E6-AP.
Although expression of UBE3A was shown initially
Introduction not to be imprinted in cultured human fibroblasts and
lymphoblasts (Nakao et al., 1994), more recent studies
In 1997, UBE3A was identified as the locus mutated in utilizing in situ hybridization in paternal UPD mice (see
Angelman syndrome (AS), a human disorder involving below) demonstrated preferential expression of the ma-
motor dysfunction and mental retardation (Kishino et ternal allele in hippocampal neurons and Purkinje cells
al., 1997; Matsuura et al., 1997). UBE3A encodes E6-AP (Albrecht et al., 1997). Imprinting with maternal expres-
ubiquitin protein ligase, an enzyme discovered on the sion was also found in human AS brain (Rougeulle et
basis of its ability to promote the degradation of the p53 al., 1997; Vu and Hoffman, 1997). The molecular basis
oncoprotein in association with the E6 protein of the for the tissue-specific imprinting is not known but may
human papilloma virus (Huibregtse et al., 1991, 1993). be related to a complex pattern of multiple promoters
The biochemistry of ubiquitination involves an E1 en- and alternative splicing for UBE3A, with evidence for
zyme to activate ubiquitin followed by one of a series the possibility of multiple isoforms of the protein with
of E2 enzymes that accept ubiquitin in covalent linkage differing N terminal sequences (Yamamoto et al., 1997).
from E1 and directly transfer the ubiquitin to target pro- All of the molecular defects found in AS patientsÐpoint
teins or to an E3 ligase that in turn ubiquitinates target mutation, large deletion, UPD, and imprinting muta-
proteins. E6-AP is a member of a subfamily of E3 ligases tionÐwould cause deficiency of E6-AP in those cell
that covalently bind ubiquitin and are characterized by types in which the paternal allele is silenced through
a C-terminal hect (homologous to the E6-AP C terminus) imprinting.
domain (Huibregtse et al., 1995; Scheffner et al., 1995). There is precedent for a mouse model of AS derived
Although E6-AP is able to ubiquitinate p53 in conjunc- through breeding animals with partial, paternal UPD
tion with the E6 viral protein in tissue culture cells, there (maternal deficiency) (Cattanach et al., 1997), but these
are conflicting data regarding its ability to interact with animals can only be obtained in limited numbers and
have paternal duplication and maternal deficiency for
z30 cM of proximal chromosome 7, so phenotypic ef-7 To whom correspondence should be addressed (e-mail: abeaudet
@bcm.tmc.edu). fects cannot be assigned to a specific gene. The UPD
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Figure 1. Preparation of a Null Mutation for Ube3a
(A) Genomic structure, targeting construct, and targeted allele for deletion of exon 2. P1, P2, and P3 are the primers designed for PCR
genotyping of mice. Abbreviations: X, XbaI; B, BamHI; H, HindIII; S, SacI; R, EcoRI; Int, internal probe; HSV, herpes simplex virus; TK, thymidine
kinase; Neo, neomycin resistance cassette; and HPRT, hypoxanthine guanine phosphoribosyl transferase.
(B±D) Genotyping of mice by Southern blotting using tail DNA. WT indicates wild-type and MT mutant bands.
(E) Genotyping of mice by PCR.
(F and G) Analysis of homozygous ES cells. Clones were analyzed by Southern blotting using the 59 probe (F) and by Northern blotting (G).
ES is wild-type ES cells, clones H1 and H2 are heterozygous, and H4 and H5 are homozygous for the null mutation. B1 is mouse brain and
B2 is mouse cerebellum.
mice were found to have mild gait ataxia, possible be- nucleotide in exon 2 as is the case in the human (Yama-
moto et al., 1997); exons are numbered by analogy tohavioral abnormalities, EEG abnormality, reduction in
skeletal size and brain weight, and late onset obesity the human (GenBank accession numbers X98021,
X98022). A targeting vector (Figure 1A) was prepared to(Cattanach et al., 1997). We have prepared mice with a
null mutation for Ube3a and find that maternal deficiency replace a 3 kb genomic DNA fragment containing exon
2 (299 bp; bp 3±302 in GenBank number U82122) thatheterozygotes (m2/p1), paternal deficiency heterozy-
gotes (m1/p2), and homozygotes (m2/p2) are viable, would delete one hundred of the most N terminal amino
acids, shift the reading frame, and thereby inactivate allalthough postnatal viability is reduced in homozygotes.
Mice with maternal deficiency have numerous pheno- putative isoforms of the protein. Homologous recombi-
nation was found at a frequency of 40% of G418 resis-typic abnormalities analogous to AS including motor
dysfunction and inducible seizures. In addition, these tant colonies in AB 2.2 mouse embryonic stem (ES) cells.
Germline transmission was obtained using multiple malemice have a deficiency of context-dependent learning
and hippocampal long-term potentiation (LTP) and have chimeras generated from two clones (Figures 1B±1E).
To further characterize the mutation, homozygous ESa major increase in cytoplasmic abundance of p53 in
Purkinje cells and some hippocampal pyramidal neurons. cells were obtained by applying selection in a high con-
centration of G418 (1.5 mg/ml) to heterozygous ES cells
and by independently targeting the second allele using,Results
an independent selectable marker (data not shown).
Two independent homozygous clones were character-Generation of a Ube3a Null Mutation
Three overlapping phage clones spanning the upstream ized by Southern blotting (H4 and H5 in Figure 1F). North-
ern blotting was performed with a cDNA probe con-coding exons of Ube3a were isolated from a mouse 129/
SvEv genomic DNA library. Exon 1 contains the first taining exons 2 and 3 as well as 59 upstream sequences,
and transcripts from the Ube3a locus were undetectabletwo nucleotides of an ATG initiation codon, with a third
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Table 1. Genotypes of Ube3a Mice at Weaning
Parental Genotypes Offspring Genotypes at Weaning
Female Male Background m1/p1 m2/p1 m1/p2 m2/p2
1/2 1/2 hybrid 39 (29%)a 68 (51%) 27 (20%)
1/2 1/2 129/SvEv 18 (32%)a 34 (60%) 5 (9%)
1/2 1/1 hybrid 62 (53%)b 56 (47%) Ð Ð
1/1 1/2 hybrid 43 (44%)c Ð 55 (56%) Ð
a Expected ratio 25% 1/1, 50% 1/2, and 25% 2/2.
b Expected ratio 50% m1/p1 and 50% m2/p1.
c Expected ratio 50% m1/p1 and 50% m1/p2.
in the homozygous clones (Figure 1G). This result indi- Morphologic and routine immunocytochemical stud-
ies were performed on maternal deficiency, paternal de-cated that the homozygous mutation is compatible with
ficiency, and homozygous mice and compared withviability of the cells, that any transcripts from the mutant
wild-type littermates at 3±4 months of age. The organsallele are unstable, and that a null allele was produced.
were grossly normal on pathological analysis, and mi-Heterozygous mice were bred to obtain homozygous
croscopic studies using formalin fixed paraffin sectionsoffspring, which were examined on a hybrid (C57BL/6
stained with hematoxylin and eosin were normal. De-and 129/SvEv) and an inbred 129/SvEv background. Al-
tailed studies with Nissl staining were also normal. Im-though there may be a slight reduction in the survival
munohistochemistry of cerebellar sections was per-of homozygotes prior to weaning on the hybrid back-
formed with an antibody to calbindin to delineate theground, there was a more substantial reduction in sur-
dendritic arborization, and no differences were detect-vival on the inbred 129/SvEv background (Table 1), with
able between wild-type and maternal deficiency micedeath observed frequently in the first 48 hr after birth.
(Figure 2). In addition, immunohistochemical analysis ofSurviving homozygotes were often growth-retarded and
the hippocampus with antibodies to MAP2 and dynor-less active and demonstrated abnormal hindlimb clasp-
phin indicated normal neuronal maturity and no abnor-ing or stationary posture when held by the tail as is seen
malities of the mossy fiber system (Figure 2). Likewise,in other mouse mutations associated with neurological
immunoreactivity with anti-ubiquitin revealed no differ-dysfunction. Because Ube3a is an imprinted locus, it
ences between mutants and wild type. Thus, thoroughwas important to distinguish heterozygotes with mater-
examination revealed normal histology of the brain,nal deficiency (m2/p1) from those with paternal defi-
which is important for the interpretation of functionalciency (m1/p2). When female or male heterozygotes
studies to be described below.were bred with normal mice of the opposite sex, there
Because of the presence of tremor, ataxia, and motorwas little if any evidence of lethality for the maternal
incoordination in AS, we examined the motor functiondeficiency mice and no evidence of lethality for the pa-
and coordination of mice with maternal deficiency. Mo-ternal deficiency mice (Table 1).
tor function was assessed by hind-paw footprint analy-
sis, bar crossing ability, and rotating rod testing on the
General Phenotype, Histology, same group of mice on the hybrid background. The hind-
and Motor Dysfunction paw footprint analysis did not reveal any obvious or
Because maternal deficiency (but not paternal defi- consistent ataxia in the gait of homozygous or maternal
ciency) with loss of function mutations in UBE3A causes heterozygous mice, although subtle differences were
AS in humans, and because it is known that expression observed in some maternal deficiency mice. The step
for the locus is exclusively maternal in portions of the length (left-left distance) and step width (left-right dis-
brain in mouse and human, it was of particular interest tance) were measured, and the left-right alternative co-
to compare maternal deficiency (m2/p1) mice that efficient was calculated (Clark et al., 1997). The mice
would be the genetic equivalent of AS with wild-type with maternal deficiency for Ube3a had a shorter step
(m1/p1) littermates. Paternal deficiency (m1/p2) mice length (5.0 6 0.3 cm versus 5.9 6 0.5 cm, p , 0.01) and
were examined but might be expected to have a normal smaller left-right step alternation coefficient (0.08 6 0.04
phenotype by analogy to humans, and homozygous versus 0.14 6 0.03, p , 0.01) when compared with val-
mice were examined to a limited extent as availability ues for wild-type littermates.
permitted. There were no obvious phenotypic abnormal- The maternal deficiency mice were tested for motor
ities in heterozygous mice with maternal or paternal coordination on a bar-crossing test in which animals
deficiency. There was a statistically significant reduction were placed at the middle of a plastic rod of 60 cm
in the weight of total body, brain, cerebral cortex, and length and 1 cm diameter. As shown in Figure 3A, mice
cerebellum in the maternal deficiency mice compared with maternal deficiency were not able to remain on the
with wild-type littermates at 18 days of age (Table 2). rod as long as wild-type littermates (mean 6 SEM for
Although the difference in brain weight persisted at 4 m2/p1 5 37.9 6 5.3 s versus 72.3 6 7.6 s for m1/p1,
months of age, the difference in body weight was no p , 0.01).
longer present. For mice with paternal deficiency, no Mice also were tested on an accelerating rotating rod
significant difference was observed for weight of total in which the speed of rotation was increased linearly
body, brain, or cerebral cortex at 18 days of age, al- from 4 to 40 rpm over 4 min. This test depends on motor
skill, and animals exhibit improvement as a result ofthough cerebellar weight may be slightly reduced.
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Figure 2. Normal Morphology in Cerebellum
and Hippocampus of Maternal Deficiency
Mice
Immunohistochemical staining is shown for
calbindin (A and B), MAP2 (C and D), and
dynorphin (E and F) with brain tissues from
maternal deficiency mice on the left and wild-
type mice on the right. Scale bars, 100 mm
for (A) through (F). Abbreviations: PL, Purkinje
cell layer; Rad, stratum radiatum; Or, Oriens
layer; DG, dentate gyrus.
motor learning. The time that maternal deficiency mice observed occasionally when handling the maternal defi-
ciency or homozygous null mice, the ability to induceremained on the rotating rod apparatus (Figure 3B) was
significantly shorter than for wild-type littermates seizures in mutant mice was examined. Seizures were
induced by vigorously scratching a pen across the metal(mean 6 SEM on day 4 for m2/p1 5 193 6 88 s versus
439 6 158 s for m1/p1, p , 0.001), but the time for grating of the mouse cage lid. The stimulus was audio-
genic and did not depend on the lid being in physicalpaternal deficiency mice (Figure 3C) was not signifi-
cantly different from wild-type (mean 6 SEM on day 4 contact with the cage containing the mouse. Suscepti-
ble mice responded with wild running and leaping fol-for m1/p2 5 381 6 150 s versus 428 6 152 s for m1/
p1, p . 0.05). Both wild-type and paternal deficiency lowed by a tonic clonic seizure, with rigid extension of
the limbs and body. Seizures typically lasted 10±20 s,mice exhibited improvement in fall-off time over the 5
day period of testing that is likely a manifestation of and mice occasionally died as a result of the seizure.
The stimulus did not induce seizures in wild-type ormotor learning in the task (Figures 3B and 3C), while
the maternal deficiency mice exhibited somewhat less paternal deficiency mice on the hybrid background, but
seizures were detected in 20%±30% of maternal defi-improvement. These deficits in the mice are analogous
to AS patients whose ataxia ranges from a moderately ciency or homozygous mice (Table 3). On the inbred
129/SvEv background, seizures were detected in 11%unsteady gait to an inability to walk independently.
of wild-type mice and 18% of paternal deficiency mice,
but they occurred in 85% of 20 maternal deficiency miceSeizures in Ube3a Null Mice
Because seizures occur in z95% of AS patients (Saitoh and 100% of 5 homozygotes (Table 3); p 5 , 0.001 for
maternal deficiency compared with wild-type on 129/et al., 1994), and because tonic clonic seizures were
Table 2. Comparison of Body Weight and Brain Weight of Ube3a Maternal Deficiency and Paternal Deficiency Mice*
Weights (g)
Genotype Age Number Body Brain Cortex Cerebelleum
m1/p1 18 days 9 8.2 6 0.5 0.38 6 0.02 0.14 6 0.01 0.048 6 0.006
m2/p1 18 days 5 7.2 6 1.0 0.35 6 0.02 0.12 6 0.02 0.041 6 0.005
p , 0.05b p , 0.005 p , 0.005 p , 0.02
m1/p1 4 months 7 27.2 6 2.9 0.44 6 0.02 0.17 6 0.01 0.062 6 0.003
m2/p1 4 months 9 28.9 6 2.6 0.39 6 0.03 0.15 6 0.01 0.051 6 0.004
p . 0.05 p , 0.005 p , 0.005 p , 0.001
m1/p1 18 days 10 8.19 6 0.7 0.37 6 0.02 0.14 6 0.01 0.051 6 0.002
m1/p2 18 days 7 8.09 6 0.8 0.36 6 0.02 0.14 6 0.005 0.047 6 0.004
p 5 0.77 p 5 0.15 p 5 0.58 p 5 0.048
a Mice were on the hybrid background.
b p values by t test.
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Figure 3. Motor Dysfunction in Maternal De-
ficiency Mice
(A) Bar-crossing test. A total of eight animals
of each genotype were tested at between 8
and 12 weeks of age. Maternal deficiency
mice maintain their balance on a thin rod for
a significantly shorter time than wild-type lit-
termates (ANOVA: F 5 4.145, p , 0.01).
(B and C) Rotating rod test. Maternal defi-
ciency mice (B) had significantly shorter la-
tency-to-fall±off time than wild-type lit-
termates (ANOVA: day 1, F 5 27.67, p , 0.001;
day 2, F 5 28.45, p , 0.001; day 3, F 5 55.17,
p , 0.001; day 4, F 5 87.6, p , 0.001; and
day 5, F 5 71.30, p , 0.001). No significant
difference for the latency-to-fall±off time was
found between paternal deficiency mice (C) and wild-type littermates on the rotating rod test. (ANOVA: day 1, F 5 0.646, p . 0.05; day 2, F
5 2.222, p . 0.05; day 3, F 5 2.443, p . 0.05; day 4, F 5 1.449, p . 0.05; and day 5, F 5 4.793, p . 0.03).
SvEv background. It is known that susceptibility to in- opportunity to evaluate the imprinting of Ube3a in a
gene-specific model. Analysis of expression in hippo-ducible seizures varies among mouse strains, and 129/
SvEv may be a seizure-prone strain similar to DBA/2 campal neurons (Figures 4A±4C) and Purkinje cells (Fig-
ures 4D±4F) demonstrated an absence of detectablemice (Vicari, 1951). Combining the data on both genetic
backgrounds, it is clear that maternal deficiency mice expression in these cell types in maternal deficiency
mice, while expression in paternal deficiency mice wasand homozygotes for the null mutation have a substan-
tially increased frequency of inducible seizures. This not distinguishable from wild-type. The relative expres-
sion of the paternal and maternal alleles for Ube3a variessusceptibility to seizures correlates well with the high
incidence of quite severe epilepsy in AS. substantially in different parts of the brain, and the abun-
dance of transcripts was approximately equal in mater-EEG recordings were obtained in awake, active mice
on the hybrid background. In the maternal deficiency nal and paternal deficiency mice for many regions as
exemplified by piriform cerebral cortex (Figures 4G±4I).mice (n 5 2), the abnormalities were nearly continuous,
showing abundant bilateral 3 s spike wave activity inter- These results confirmed the predominant or exclusive
expression of the maternal allele in hippocampal neu-mixed with polyspike and slow wave discharges. Longer
episodes were accompanied by behavioral immobility, rons and Purkinje cells, and this pattern of cell-specific
expression correlates well with the phenotypic featuresas seen in absence epilepsy. Paternal deficiency mice
(n 5 2) showed predominantly normal electrographic of seizures, learning deficit, and ataxia in humans and
with the seizures, context-dependent learning abnor-activity. No photoconvulsive response was obtained by
1±45 Hz photic stimulation in any of the mutants tested, malities (see below), and motor dysfunction in maternal
deficiency mice.and the respective littermate control mice (n 5 5) failed
to show any abnormal EEG activity. The abnormal syn-
chronization of the EEG in maternal deficiency mice
Defective Context-Dependent Learningindicates that the Ube3a gene defect can contribute to
in Maternal Deficiency Micepathological cerebral excitability that is analogous to
Because of the severe learning deficit in human ASthe EEG abnormalities and mixed seizure pattern seen
and the maternal expression of Ube3a in hippocampalin AS (Minassian et al., 1998).
neurons in mice, associative learning was evaluated in
maternal deficiency mice by using a fear conditioningImprinted Expression of Ube3a in Brain
paradigm. Fear conditioning is a form of associativeThe genetic and molecular data, particularly loss of func-
learning found in many species and in rodents exhibitstion mutations in UBE3A, indicate that the AS phenotype
both contextual and cued forms. In context-dependentis caused by maternal deficiency for the locus, and ma-
fear conditioning, the animal learns to associate a partic-ternal expression was found in hippocampal neurons
ular environment (context) with an aversive stimulus.and Purkinje cells of mice with partial paternal UPD
This form of fear conditioning has been shown to be(maternal deficiency) of chromosome 7 (Albrecht et al.,
both amygdala- and hippocampus-dependent (Kim and1997). The availability of a null mutation in Ube3a in the
Fanselow, 1992). In tone-dependent (cued) fear condi-mice with evidence for the absence of transcripts from
tioning, the animal learns that an auditory stimulus pre-the mutant allele (see Figure 1G, above) provided the
dicts an aversive stimulus; this form of conditioning is
known to be insensitive to hippocampal lesion (Phillips
Table 3. Inducible Seizures in Ube3a Mutant Mice and LeDoux, 1992; Kim et al., 1993; McNish et al., 1997).
In the experimental design that we used, an initial neutralGenotype Hybrid 129/SvEv
environment (an experimental chamber suitable for rec-
m1/p1 0/36a 4/36 ognition by the animal at a later time) and a tone were
m1/p2 0/22 3/17
paired with an adverse stimulus (an electric foot shock).m2/p1 6/28 17/20
A fear response (i.e., a conditional freezing behaviorm2/p2 6/21 5/5
characterized by a motionless, crouching posture) was
a Data are each mouse tested once.
assessed at 5 s intervals to determine the response to
Neuron
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Figure 4. Brain-Specific Imprinted Expres-
sion Pattern for Ube3a
Comparison of the expression of Ube3a in
maternal deficiency, paternal deficiency, and
wild-type mice in hippocampus (A±C), cere-
bellar Purkinje cells (D±F), and piriform cere-
bral cortex (G±I). The sections were stained
with Hoechst 33258 fluorescent dye and visu-
alized by fluorescence. Expression of Ube3a
is represented by silver grains shown in red.
For each row, the genotypes are wild-type
(m1/p1) on the left, paternal deficiency (m1/
p2) in the middle, and maternal deficiency
(m2/p1) on the right. Scale bars, 500 mm.
Abbreviations: CA, cornu ammonis; dg, den-
tate gyrus; and pl, Purkinje layer.
the subsequent presentation of context or tone. The test- (Figure 5A). This observation indicates that maternal de-
ficiency mice exhibit normal sensory responses to theing was performed in three steps. First, in the training
phase of the experiment, mice were placed in the experi- foot shock.
When wild-type and maternal deficiency mice weremental chamber and received three pairings of tone with
subsequent foot shock, each pairing separated by 60 compared for context-dependent learning 24 hr after
training, maternal deficiency mice demonstrated sub-s. Second, context-dependent testing was performed
24 hr later to determine if the animal recognized the stantially less freezing behavior in response to the envi-
ronment of the experimental chamber compared withadverse environment of the previous day. Third, tone-
dependent testing in a novel environment was per- wild-type mice (Figure 5B). Immediately following the
context-dependent testing, the same mice were testedformed immediately following step 2 to determine if the
animal responded to the tone. The maternal deficiency for tone-dependent (cued) conditioning in a novel cham-
ber by exposure to the tone continuously for 3 min with-and wild-type mice behaved similarly, with marked
freezing behavior during the training phase of the test out administration of shock. When the tone was pre-
Figure 5. Selective Deficit in Context-Dependent Fear Conditioning in Maternal Deficiency Mice
The same group of maternal deficiency (n 5 12) and wild-type (n 5 12) mice on the hybrid background were used for all studies. In the training
phase of context- and tone-dependent fear conditioning (A), wild-type and maternal deficiency mice displayed a comparable degree of freezing
immediately after the tone and foot shock. In context-dependent fear conditioning (B), maternal deficiency mice displayed significantly less
freezing than wild-type littermates when returned to the original chamber 24 hr later. Significant p values (,0.001) were seen at each sampling
period and for the total data by X2 test. For tone-dependent fear conditioning (C), maternal deficiency mice and wild-type mice displayed a
comparable degree of freezing when presented with tone in the novel context immediately after context-dependent testing. Tone is indicated
by horizontal bars in (A) and (C) and foot shock by arrows in (A).
Impaired Learning and LTP in Angelman Mice
805
Figure 6. Impairment of Hippocampal LTP in Maternal Deficiency Mice
(A) Summary of field potential recordings (mean 6 SEM) from wild-type (n 5 17 slices, 11 animals) and maternal deficiency mice (14 slices,
6 animals) from the CA1 region. Baseline measurements were taken for at least 20 min to confirm stability. Stimulation intensity was adjusted
for responses that were z50% of the maximal fEPSP. Two 100 Hz, 1 s stimuli were given at time 0. Each point is a 2 min average of six
individual fEPSP measurements. The inset presents extracellular field recordings from a representative experiment during a baseline interval
and 60 min after induction of LTP for a wild-type (m1/p1) and a maternal deficiency (m2/p1) slice. Scale bars for inset, 2 mV and 4 ms.
(B and C) Baseline synaptic responses were similar for maternal deficiency and wild-type mice.
Plots of fiber volley amplitude versus stimulus strength and fEPSP slope versus fiber volley amplitude revealed no differences between wild-
type and maternal deficiency mice. Results shown are from nine slices for wild-type and eight slices for maternal deficiency mice.
(D) Paired-pulse facilitation is not impaired in maternal deficiency mice. The magnitude of the second response is presented as a percentage
of the first response. Results shown are from five slices for wild-type and seven slices for maternal deficiency animals.
(E) Responses to tetanic stimulation are not different between maternal deficiency and wild-type mice. Total depolarization (the integral of
the tetanic depolarization response) is presented for wild-type (n 5 6; upper trace) and maternal deficiency (n 5 6; lower trace) animals. Scale
bars for inset, 2 mV and 90 ms.
sented, both wild-type and maternal deficiency mice the possibility of a hippocampal-dependent learning
deficit, and the behavior may correlate with the hippo-displayed indistinguishable freezing behavior (Figure
5C). The decreased freezing response exhibited at later campal deficiency of Ube3a expression. The learning
deficit may be analogous to the very severe cognitivetimes during the continuous presentation of the tone
likely results from extinction of the fear response. These impairment observed in AS.
studies demonstrated that mice with maternal defi-
ciency for Ube3a had a normal ability to learn and to Defective LTP in Maternal Deficiency Mice
Because of the mental retardation in AS patients, theretain the information that the tone predicted the shock,
but they were specifically deficient in context-depen- context-dependent learning deficit in maternal defi-
ciency mice, and the absence of hippocampal expres-dent learning when returned to the environment of the
conditioning chamber. These results are compatible with sion of Ube3a in these mice, we studied the mice for
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LTP in hippocampal slices. We analyzed LTP at Schaffer
collateral synapses in area CA1, using high-frequency
stimulation (two 1 s, 100 Hz stimuli separated by 20
s) as the LTP-inducing protocol. In these experiments,
extracellular recording of field excitatory postsynaptic
potentials (fEPSPs) was used to monitor synaptic trans-
mission. As shown in Figure 6A, high frequency stimula-
tion using this protocol reliably induced stable LTP in
wild-type animals. However, when maternal deficiency
mice were tested for LTP, they exhibited a marked defi-
ciency (Figure 6A). In these mice, repetitive high fre-
quency stimulation elicited only a transient potentiation,
similar to that routinely reported as short-term potentia-
tion. Maternal deficiency mice exhibited apparently nor-
mal synaptic responses to Schaffer collateral stimula-
tion. Input±output curves for stimulus intensity versus
fiber volley amplitude did not differ between maternal
deficiency and wild-type mice (Figure 6B) nor did the
relationship between fiber volley amplitude and field
EPSP slope (Figure 6C). Maternal deficiency mice also
did not differ significantly from wild-type in terms of
paired-pulse facilitation (Figure 6D) or in their immediate
responses to tetanic stimulation (Figure 6E). Thus, ma-
ternal deficiency mice exhibit a deficit in long-term syn-
aptic potentiation in the hippocampus in the absence
of observable defects in baseline synaptic responses.
Increased Cytoplasmic p53 in Postsynaptic Neurons
E6-AP was discovered on the basis of its E6-mediated
interaction with p53, but the biological significance of
any possible interaction in vivo between E6-AP and p53
in the absence of viral proteins is uncertain. The avail-
ability of a null mutation in mice permitted the assess-
ment of the abundance of p53 in the tissues of mice
with various genotypes. Toward this end, immunohisto-
chemistry of p53 was performed on sections of brain
Figure 7. Increased p53 in Brain of Maternal Deficiency Mice and ASfrom wild-type and mutant mice. The most remarkable
(A±F) Immunohistochemical staining for p53 with tissues from mater-finding in these studies was an increased cytoplasmic
nal deficiency mice on the left and wild-type mice on the right; scaleabundance of p53 in Purkinje cells of maternal defi-
bars, 100 mm for (B), (F), and (H) and 500 mm for (D). Abbreviation:ciency and homozygous null mice compared with very
PC, Purkinje cells.
low or undetectable staining in paternal deficiency or (A and B) Cerebellum showing increased cytoplasmic staining for
wild-type mice (Figures 7A and 7B, homozygous not p53 in Purkinje cells of maternal deficiency mice.
shown). Significant differences were also observed in (C±F) Hippocampus showing increased staining for p53 for selected
pyramidal neurons clustered in the CA region of maternal deficiencyhippocampus, where staining was again undetectable
mice.in paternal deficiency or wild-type mice, but intense
(G and H) Immunohistochemistry for p53 in AS brain (left) comparedstaining was seen in the cytoplasm of selected pyrami-
with control (right).
dal neurons of the CA1, CA2, and CA3 regions of the
hippocampus in maternal deficiency and homozygous
mice (Figures 7C±7F, homozygous not shown). Moder-
ate staining was also seen in some other regions of the Given the increased cytoplasmic p53 in mouse brain,
selected paraffin blocks from a case of AS were studiedbrain including mitral cells of the olfactory bulbs and
pontine neurons (data not shown) in maternal deficiency with anti-p53 antibody. The patient died at 21 years of
age with a clinical diagnosis of AS (Jay et al., 1991). Inand homozygous mice.
Mice of each genotype were also assessed for the the cerebellum, there was a profound loss of Purkinje
and internal granule neurons, but the few surviving Pur-abundance of transcripts for p53 in brain, with attention
to cerebellum and hippocampus. By in situ hybridiza- kinje cells revealed substantial immunoreactivity with
p53, whereas the cerebellum of two non-Angelman casestion, low levels of transcripts were found in brain, but
there were no significant differences between geno- showed no immunoreactivity (Figures 7G and 7H). Hip-
pocampal tissue from AS was not available for analysis.types (data not shown), indicating that the increased
abundance of p53 protein in maternal deficiency and Together, the findings in the mouse and human demon-
strate that E6-AP can regulate levels of p53 in postmi-homozygous mice represents a posttranscriptional and
most likely a posttranslational effect. totic neurons in the absence of the E6 viral protein.
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Discussion protein degradation. The biochemistry of ubiquitination
is complex, with an E1 enzyme for activation of ubiquitin,
a series of E2 enzymes capable of ubiquitinating sub-We have generated a null mutation for Ube3a and found
that maternal deficiency mice closely mimic the pheno- strates directly, and an even more extensive series of
E3 ligases that can promote ubiquitination by E2 en-type of human AS. The maternal deficiency mice have,
by several criteria, a normal neuroanatomy but display zymes or be directly involved in the ubiquitination of
substrates (reviewed by Hochstrasser, 1996b; Baumeis-a deficit of context-dependent learning and LTP. The
mouse data imply that the cognitive impairment in AS ter et al., 1998; Ciechanover and Schwartz, 1998). There
are many mutations identified in yeast, and some of themay be associated with a defect of LTP in humans. The
data also suggest that ubiquitin-dependent proteolytic genes are essential for viability (Hochstrasser, 1996b).
A mutation in the ubc-2 locus of C. elegans causesdegradation may affect an important component of the
biochemistry of LTP in mammals, although more indirect lethality and abnormal larval development (Zhen et al.,
1996). A mutation in an E2 ubiquitin-conjugating enzymeeffects are possible. The cytoplasmic abundance of p53
is greatly increased in the Purkinje cells and in a subset in Drosophila affects the bendless gene, and the mutant
flies have abnormalities of axon guidance and neuronalof hippocampal neurons in the maternal deficiency mice,
with similar findings in human AS, indicating that the connectivity (Oh et al., 1994). A proviral integration into
the UbcM4 mouse locus encoding an E2 ubiquitin-con-E6-AP protein can affect the metabolism of p53 in post-
mitotic neurons. This mouse model provides the oppor- jugating enzyme results in a recessive mutation with a
placental defect and embryonic lethality (Harbers et al.,tunity to identify other protein targets of E6-AP, in partic-
ular those involved in modulating LTP. 1996). The human homolog of murine UbcM4 is Ubch7,
and there is evidence for interaction between the Ubch7
protein and E6-AP (Kumar et al., 1997). A mutation inA Gene-Specific Model for AS
another E3 ubiquitin protein ligase encoded by the ItchThe phenotype in the mice with maternal deficiency for
locus in the mouse causes a complex spectrum of immu-Ube3a can be compared with AS. The impairment in
nological and inflammatory diseases (Perry et al., 1998).bar-crossing and rotating rod testing in these mice cor-
The spectrum of phenotypes that may be associatedrelates well with the ataxia and motor incoordination in
with mutations in the ubiquitin-dependent proteasomalhuman AS. Similarly, the presence of inducible seizures
pathway in mammals is unknown but includes embry-is consistent with the high incidence of epilepsy in hu-
onic lethality and more specific phenotypes such asmans, and the defect in context-dependent learning in
seen with AS and the itchy phenotype. Many more hu-the mice may correlate with the relatively severe cogni-
man disorders of ubiquitination or proteasomal degra-tive impairment in AS. From a structure±function per-
dation may remain to be delineated.spective, these phenotypic features correlate well with
the absence of expression of Ube3a in hippocampal
neurons and Purkinje cells in maternal deficiency mice Deficiency of Ube3a Impairs Context-Dependent
related to the tissue-specific silencing of the paternal Learning and Hippocampal LTP
allele. The present studies implicate the ubiquitin pathway in
The phenotype in the maternal deficiency mice is quite hippocampal LTP. Until further studies are performed,
consistent with the mild gait ataxia, behavioral abnor- it is impossible to determine whether the Ube3a gene
malities, EEG abnormality, and reduction in skeletal size product plays a direct role in the signal transduction
and brain weight previously reported for the paternal cascades operating to elicit LTP, or whether loss of
UPD mice (Cattanach et al., 1997), but the null mutation Ube3a leads to secondary effects that impinge upon the
reported here permits the specific assignment of pheno- LTP induction pathways.
typic and biochemical changes to the Ube3a locus. The Our results are the first to implicate the ubiquitin path-
availability of germline transmission for the Ube3a mu- way in long-term synaptic plasticity and learning in a
tation permits the production of unlimited numbers of mammalian system. Interestingly, the ubiquitin pathway
animals so that systematic studies of the phenotypeÐ has already been identified as playing an integral role
including detailed behavioral, biochemical, and physio- in learning and long-term facilitation of transmitter re-
logical studiesÐwill be feasible. Although it is likely that lease in the marine invertebrate Aplysia. In that organ-
there are subtle genotype±phenotype differences in hu- ism, long-term behavioral sensitization is in part sub-
mans and mice between the large deletion, UPD, imprint- served by ubiquitin-mediated proteolysis of protein
ing mutation, and single gene mutation defects (Jiang kinase A (PKA) regulatory subunits (Bergold et al., 1992;
et al., 1998; Minassian et al., 1998), the loss of function Chain et al., 1995; Hegde et al., 1997). This results in
mutations in UBE3A found in clinically typical AS pa- persistent activation of PKA, which serves as a memory
tients strongly indicates that the major aspects of the trace to sustain synaptic facilitation and behavioral sen-
phenotype are attributable to maternal deficiency for sitization through phosphorylation of its downstream
this locus, and the findings in the mice reported here effectors (Sweatt and Kandel, 1989; Ghirardi et al., 1995).
are consistent with this interpretation. It is unlikely that an identical mechanism operates in
hippocampal LTP, as PKA is not persistently activated
in this system (Chetkovich et al., 1991; Roberson andGenetic Disorders of Ubiquitination
and Proteasomes Sweatt, 1996). However, other protein kinases that are
persistently activated in LTP, such as protein kinaseAS is the first human disorder associated with a defect
in the ubiquitin-dependent proteasomal pathway for C (PKC) and calcium/calmodulin-dependent kinase II
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(CaMKII) (Klann et al., 1991, 1993; Fukunaga et al., 1993; It is not possible to put the interaction between E6-
AP and p53 into an integrated biological context givenSacktor et al., 1993; Barria et al., 1997), are certainly
candidates for regulation via this mechanism. This is a the enormous complexity of information regarding the
biochemistry of p53. The p53 protein is also subjectparticularly appealing prospect in the case of PKC,
where proteolytically activated forms of the kinase have to ubiquitination by MDM2, another E3 ubiquitin ligase
(Haupt et al., 1997; Kubbutat et al., 1997). The p53±been observed to increase in LTP (Sacktor et al., 1993;
Powell et al., 1994). MDM2 interaction creates an autoregulatory feedback
loop whereby p53 increases the transcription of MDM2,Maternal deficiency mice exhibit a selective deficit in
contextual associative learning. This type of learning while MDM2 promotes the degradation of p53 (Piette et
al., 1997; Ko and Prives, 1998). The accumulation of p53has been observed previously to be sensitive to hippo-
campal lesions, and this phenotype correlates well with in Purkinje cells and hippocampal neurons is prominent
in the cytoplasm, although more subtle increases in thethe maternal expression of Ube3a in the hippocampus.
In fact, the imprinting of the Ube3a gene results in a nucleus cannot be ruled out, and nuclear accumulation
might occur earlier in development when the precursorsrelatively limited pattern of genetic deficiency that is
particularly prominent in the hippocampus and cerebel- for the involved cells are still dividing. Although nuclear
localization of p53 is prominent and is essential for regu-lar Purkinje neurons. Based on the data available at
present, by far the most parsimonious explanation for lation of the cell cycle (Shaulsky et al., 1991), its subcellu-
lar trafficking is highly regulated. Localization of p53 isthe associative learning deficit exhibited is that it is due
to a hippocampal defect. predominantly cytoplasmic in the G1 phase of the cell
cycle (Shaulsky et al., 1990), so it is not surprising toAs described above, maternal deficiency mice exhibit
a loss of LTP in area CA1 of the hippocampus. Based find this localization in postmitotic neurons. Of the two
E3 ligases known to ubiquitinate p53, E6-AP is foundon our observations in the Ube3a maternal deficiency
mice, it is therefore likely the case that humans with both in cytoplasm and the nucleus (Hatakeyama and
Weissman, 1997), while MDM2 is restricted to the nu-AS have deficits in hippocampal LTP as part of their
complex phenotype. At present, LTP is the best candi- cleus (Pomerantz et al., 1998).
date for a cellular mechanism contributing to mamma-
lian learning and memory (Stevens, 1998). While loss of Pathogenesis of AS
LTP is not universally correlated with learning deficits, Since E6-AP is known to be a ubiquitin protein ligase,
a wide variety of pharmacologic and genetic studies it can be hypothesized that failure to ubiquitinate target
in rodents, including the present study, have demon- proteins and promote their degradation would be a key
strated a linkage of learning deficits, with derangements aspect of the pathogenesis of AS, although ubiquitina-
in hippocampal LTP. It is therefore intriguing to consider tion can mediate effects other than protein degradation
that the profound learning deficits in AS may be due (Chen et al., 1996; Hicke and Riezman, 1996; Hochstras-
to a loss of LTP in these patients. However, several ser, 1996a). Phenotypic effects would likely be limited
alternative possibilities also exist, as the present studies to those cell types in which the paternal allele is silenced,
did not assess such parameters as endogenous neu- and expression is dependent on the maternal allele. The
ronal firing patterns, long-term depression (LTD), and two proteins known to be ubiquitinated by E6-AP at
NMDA receptor±independent synaptic plasticity in the present are p53 (Huibregtse et al., 1991, 1993) and a
maternal deficiency mice. protein designated HHR23A that has sequence homol-
ogy to the yeast RAD23 protein (Masutani et al., 1994;
Kumar et al., 1997). Although increased abundance of
E6-AP Affects Abundance of p53 in Purkinje p53 could contribute to cellular dysfunction and eventu-
Cells and Hippocampal Neurons ally cell death through apoptosis, there is insufficient
Significant questions to be addressed include whether evidence at present to suggest that p53 may be directly
E6-AP is an important physiological regulator of p53, involved in the pathogenesis of AS, and there are likely
whether p53 is one of a small number of potential targets to be numerous other unknown proteins that are ubiqui-
for E6-AP or represents one of dozens or even hundreds tinated by E6-AP. To further delineate the pathogenesis
of such targets, and whether p53 represents an impor- of AS, gene products that are candidates to be ubiquiti-
tant effector molecule in the pathogenesis of AS. As nated by E6-AP could be assessed immunohistochemi-
reviewed in the Introduction, it has been uncertain cally, as has been done for p53, to determine if the
whether E6-AP interacts with p53 in vivo in the absence abundance of specific proteins is increased in Purkinje
of the E6 viral protein. The finding of a substantially cells, hippocampal neurons, or other cell types.
increased abundance of cytoplasmic p53 in Purkinje
cells and a subset of hippocampal neurons in the mater-
Experimental Procedures
nal deficiency mice, with similar findings in brain from
an Angelman patient, provides strong evidence that E6- Gene Targeting and Generation of Ube3a Deficiency Mice
A mouse Ube3a cDNA clone (GenBank accession number U82122)AP can regulate the abundance of p53 in postmitotic
was used to screen a 129/SvEv genomic DNA library provided byneurons, presumably through ubiquitin-mediated pro-
Dr. Allan Bradley. The targeting vector was designed to delete a 3teasomal degradation, although an indirect effect is pos-
kb fragment from SacI to XbaI, which contains exon 2 (299 bp) ofsible. Although it is possible that an unknown endoge-
Ube3a. The plasmid (pL13) contained a neo-selectable marker; in
nous protein might substitute for E6, the in vivo findings addition, a loxP site and 59 portion of an HPRT-selectable marker
increase the probability that the interaction of p53 and were included to facilitate the preparation of large chromosomal
deletions downstream of Ube3a in future studies. Vector DNA (15E6-AP is physiologically important.
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mg) was linearized in the plasmid backbone and electroporated into Immunohistochemistry
Tissues were harvested from mice on the hybrid background at1 3 107 AB2.2 ES cells as described previously (Bullard et al., 1996).
G418-resistant clones were screened by Southern blotting using a 12±16 weeks of age, fixed in 10% buffered formalin, embedded in
paraffin, and sectioned. Antigen retrieval was performed by heating59 flanking probe. The positive clones were expanded and confirmed
by Southern blotting using various probes as depicted in Figure the slides in 0.1 M citrate buffer (pH 6.4) using a microwave three
times for a total of 3 min. Endogenous peroxide blocking was done1 prior to injection. Targeted clones were injected into C57BL/6J
blastocysts by standard procedures. For PCR-based genotyping, in 0.3% H2O2 in PBS with 1.0% Triton X-100. A rabbit polyclonal
antibody against full length p53 of human origin at 1:200 dilutionthe primer sites were as diagrammed in Figure 1A. The primer se-
quences were as follows: P1/genomic forward, 59-ACTTCTCAAGGT (FL-393, Santa Cruz Biotechnology, San Cruz, CA), a monoclonal
antibody to MAP2 at 1:500 dilution (Sigma Bioscience, St. Louis,AAGCTGAGCTTGC-39; P2/reverse, 59-GCTCAAGGTTGTATGCCTT
GGTGCT-39; and P3/HPRT forward, 59-TGCATCGCATTGTGTGAGT MO), a rabbit antibody to dynorphin A at 1:1500 dilution (Peninsula
Laboratories, Belomont, CA), and a monoclonal antibody to calbin-AGGTGTC-39. PCR cycling conditions were 948C for 45 s, 578C for
45 s, and 728C for 45 s for 35 cycles. Multiple high percentage din-D at 1:1000 dilution were incubated at 48C for 24 hr for p53,
MAP2, and dynorphin antibodies and 72 hr for the calbindin antibodychimeras were then bred to C57BL/6 to score the germline transmis-
sion that was obtained for two clones. These mice were maintained followed by immunoperoxidase staining and development of color
with diaminobenzidine substrate.on a hybrid (C57BL/6 and 129/SvEv) background. Chimeras were
bred to 129/SvEv mice to establish the targeted allele on 129/SvEv
inbred background.
Fear Conditioning
Fear conditioning was conducted in a standard testing chamber
Northern Analysis (28 3 26 3 22 cm; MED Associates, Georgia, VT) with a stainless
Total RNA was isolated from ES cells and mouse tissues by the steel grated floor through which scrambled foot shock could be
CsCl gradient method (Sambrook et al., 1989). Following glyoxal/ administered. The chamber was placed inside a sound-attenuating
DMSO denaturation, total RNA was resolved on a 1.2% agarose gel chest with a ventilation fan and a peep hole on one side of the door
in 10 mM Na3PO4 buffer (pH 6.8). RNA was transferred to Hybond to allow the observation of the mouse in the chamber. Freezing was
N1 membrane, and a probe was prepared from mouse cDNA (nucle- assessed by a time sampling procedure in which an observer blind
otide 1±1421 of GenBank accession number U82122, with an addi- to the mouse genotype scored each mouse every 5 s. Mice were
tional 240 bp of upstream sequence). scored as either a 1 (freezing posture) or 0 (not freezing posture),
and the scores were averaged over a 1 min interval and converted
to a percent score. A pilot study was done on wild-type animals toPreparation of Homozygous ES Cells
optimize the shock intensity and procedures, and then 12 maternalHeterozygous ES cells targeted for Ube3a were plated at 105 cells
deficiency and 12 wild-type mice on the hybrid background wereon 10 cm tissue culture dishes. Selection was applied on the next
studied at 3±4 months of age. In the conditioning phase, mice wereday with various concentrations of G418 (0.5, 1.0, 1.5, or 2.0 mg/
placed in the shocking chamber for 3 min and subsequently sub-ml). Medium was changed daily and resistant clones were picked
jected to three tones (20 s duration at 65 dB and 2.8 kHz) pairedfrom the dish with 1.5 mg/ml of G418 on day 6.
with foot shock (0.75 mA for 1 s at the end of the tone). The tone
and shock were repeated three times at 1 min intervals. Mice were
RNA In Situ Hybridization removed from the chamber 1 min after the last foot shock. The
In situ hybridization was performed on mice on the hybrid back- chamber was cleaned with 100% ethanol before each animal was
ground as described previously (Albrecht et al., 1997). placed inside. For the testing phase of context-dependent fear con-
ditioning, mice were returned to the same shocking chamber 24 hr
later, and freezing was monitored every 5 s for 5 min. The tone-Testing Motor Function
dependent fear conditioning was tested on the same mice immedi-Studies were performed with mice on the hybrid genetic back-
ately after the context-dependent fear conditioning test. Mice wereground. For footprint analysis, the hind-paws of the mice were
placed in a novel context, with some addition of food for odor.dipped into red waterproof ink, and they were placed at an open
Freezing was scored for 3 min in the absence of tone and for anotherend of a dark wooden tunnel (6 3 9 3 40 cm). The step length,
3 min with a continuous tone presented.step width, and left-right alternation coefficient were calculated as
described (Clark et al., 1997). The paired t test was used for statisti-
cal analysis.
Hippocampal Slice Preparation and Electrophysiology
For the bar-crossing test, a smooth plastic rod (1 cm diameter,
The hippocampi of 14±16-week-old mice were rapidly removed and
60 cm in length) was positioned horizontally and level and fixed at
briefly chilled in ice-cold cutting saline (110 mM sucrose, 60 mM
both ends. The test mice were placed at the midpoint of the rod,
NaCl, 3 mM KCl, 1.25 mM NaH2PO4, 28 mM NaHCO3, 0.5 mM CaCl2,and the time that each mouse remained on the rod was recorded.
5 mM D-glucose, and 0.6 mM absorbate, saturated with 95% O2Mice were given four trials per day, with 60 min intervals between
and 5% CO2). Slices 400 mm thick were prepared with a Vibratometrials for 2 consecutive days.
(Technical Products International, St. Louis, MO) and maintained at
For the rotating rod test, the model 7650 Rota-rod (Ugo Basile
least 45 min in a holding chamber containing 50% recording saline
Biological Research Apparatus, Varese, Italy) was used. Mice were
(125 mM NaCl, 2.5 mM KCl, 1.24 mM NaH2PO4, 25 mM NaHCO3, 10given one training trial 2 hr before the test, and then four trials per
mM D-glucose, 2 mM CaCl2, and 1 mM MgCl2, saturated with 95%day, with a 45±60 min interval between the trials for 5 consecutive
O2 and 5% CO2) and 50% cutting saline and then transferred to adays. No consistent difference was found within the four trials on
Fine Science Tools (Foster City, CA) interface recording chamber
a single day. Latency to fall-off time was recorded for each trial. All
maintained at 258C. No difference was found on the hybrid or inbred
trials were terminated after 10 min. ANOVA with repeated measure
129/SvEv background, and a majority of the mice studied were on
was used for the statistical analysis.
the inbred 129/SvEv background. Electrophysiological recordings
were conducted 2±6 hr after dissection essentially as previously
described (Chetkovich et al., 1991). Stimuli were delivered to Schaf-Seizures and Electrocorticographic Recordings
Seizures were induced by scratching a plastic pen across a stainless fer collateral inputs into area CA1 by using a bipolar Teflon coated
platinum electrode. Recording electrodes were made from glasssteel cage grating as rapidly and intensively as possible until sei-
zures occurred or for a maximum of 45 s. Each animal was tested filament microcapillaries with a Narishige (Greenvale, NY) horizontal
electrode puller. Electrodes were filled with recording saline andonce at between 5 and 10 weeks of age.
EEG recordings were performed as described previously (Catta- had a direct current resistance of 1±2 MV. Recording electrodes
were placed in the dendritic region (stratum radiatum) of CA1. LTPnach et al., 1997). All cortical activity was analyzed by an observer
blind to the genotype. All mice were 4±5 months of age and were was induced after at least 20 min of stable baseline recording by
using two 1 s, 100 Hz tetani, 20 s apart at baseline stimulus intensity.on the hybrid background.
Neuron
810
Room temperature recording and a modest tetanic stimulation pro- Ciechanover, A. and Schwartz, A.L. (1998). The ubiquitin-protea-
some pathway: the complexity and myriad functions of proteinstocol were used in these experiments to increase the sensitivity of
death. Proc. Natl. Acad. Sci. USA 95, 2727±2730.detecting derangements of LTP. Baseline stimulus intensity was
chosen to be an intensity that produced a fEPSP at z50% of the Clark, H.B., Burright, E.N., Yunis, W.S., Larson, S., Wilcox, C., Hart-
maximal response. Within each experiment, each data point is an man, B., Matilla, A., Zoghbi, H.Y., and Orr, H.T. (1997). Purkinje cell
average from six individual traces, calculated as an initial EPSP expression of a mutant allele of SCA1 in transgenic mice leads to
slope. Data were normalized to pretetanus baseline within each disparate effects on motor behaviors, followed by a progressive
experiment. The experimenter was blind to the genotypes for almost cerebellar dysfunction and histological alterations. J. Neurosci. 17,
all observations. 7385±7395.
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